Freedom251 › AI Drug Discovery Software
CONECTA
Facts from CONECTA's own pages
- Biology-first discovery
- The platform uses a biology-first, mechanism-agnostic approach to match chemistry to desired disease activity profiles. · montai.com, 14 Nov 2026
- Candidate timeline
- Montai says it can advance hits to potent and selective oral candidates in approximately 24 months. · montai.com, 14 Nov 2026
- Chemical library
- Montai says its curated chemical space contains more than 3 billion unique compounds. · montai.com, 14 Nov 2026
- Complex targets
- The platform seeks drug discovery solutions for complex protein targets, including those with no known binding pockets. · montai.com, 14 Nov 2026
- Data and pathways
- Its multimodal foundation models are trained on more than 1 billion curated and proprietary data points and over 100 biological pathways across five therapeutic areas. · montai.com, 14 Nov 2026
- Founded
- 2019 · montai.com, 21 Oct 2026
- Headquarters
- Montai Therapeutics is headquartered at 26 Landsdowne Street, Cambridge, Massachusetts 02139. · montai.com, 14 Nov 2026
- Hit rate claim
- Montai reports an 80-fold higher hit rate than traditional drug screening and ninefold higher than public machine-learning models. · montai.com, 14 Nov 2026
- Integrated expertise
- The platform brings together biologists, chemists, toxicologists, CMC experts, drug developers, and machine-learning experts. · montai.com, 14 Nov 2026
- Intended users
- The platform is described as empowering drug developers to find oral solutions for difficult biology in chronic inflammatory disease. · montai.com, 14 Nov 2026
- Partnership inquiries
- Montai invites partnership inquiries by email. · montai.com, 14 Nov 2026
- Platform access
- Montai describes its website as an informational resource about the platform, rather than presenting it as a downloadable software product. · montai.com, 14 Nov 2026
- Predictive models
- The platform includes more than 60 drug-property models. · montai.com, 14 Nov 2026
- Privacy contact
- Montai lists [email protected] for privacy questions and requests. · montai.com, 14 Nov 2026
- Purpose
- CONECTA is an AI-powered drug discovery platform designed to turn underexplored natural chemistry into oral therapies. · montai.com, 14 Nov 2026
- Scaffolds
- Montai reports that 99% of its Anthromolecule library scaffolds are unique. · montai.com, 14 Nov 2026
Where CONECTA stands on Freedom251
- AI Drug Discovery Software#13 of 33